Ian Mortimer - PRESIDENT, CEO & INTERIM CFO, Director at Xenon Pharmaceuticals Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
PRESIDENT, CEO & INTERIM CFO, Director
Stock Symbol
XENE on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Ian Mortimer - trading volume in the past year for Xenon Pharmaceuticals Inc.

Holdings reported by Ian Mortimer for Xenon Pharmaceuticals Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Shares 31.3K $1.26M $40.16 Oct 1, 2025 Direct
Common Shares 14.3K $561K $39.21 Oct 1, 2025 By Spouse
Share Option (Right to Buy) 275K Mar 12, 2025 Direct Common Shares
Restricted Share Units 50K Mar 12, 2025 Direct Common Shares
Stock Option (Right to Buy) 0 Oct 1, 2025 Direct Common Shares

Transactions reported by Ian Mortimer for Xenon Pharmaceuticals Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.